Appili Therapeutics
Canada-based anti-infective pharmaceutical development company. Learn more
Launch date
Employees
Market cap
€2.8m
Enterprise valuation
€9m (Public information from Sep 2024)
Share price
CAD0.03 APLI.TO
Halifax Nova Scotia (HQ)
Authorizing premium user...